Importantly, in recent years, mounting pieces of evidence suggest that GSH adducts, controlled by glutaredoxins (Glrxs) as a redox switch, participate in various human diseases including cancer to cardiovascular diseases.14, 15. The gene discussed is GLRX; the disease is cardiovascular disorder.